Stockscreener 앱 받기
7.07
0.56%
-0.04
Instil Bio Inc 주식(TIL)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - Your Wyoming Link
(TIL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Forecast Cut: Can Instil Bio Inc scale operations efficientlyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - GlobeNewswire Inc.
Published on: 2026-01-13 02:54:06 - Улправда
Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock see PE expansionJuly 2025 Drop Watch & Fast Entry Momentum Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock benefit from green energy trendsMarket Risk Summary & Community Supported Trade Ideas - Улправда
Portfolio Update: Is Instil Bio Inc. stock a good choice for value investorsJuly 2025 Opening Moves & Daily Volume Surge Signals - Улправда
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com South Africa
Why analysts remain bullish on Instil Bio Inc. stockMarket Entry Points & Low Risk Trading Portfolio - Улправда
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Australia
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Nigeria
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M By Investing.com - Investing.com South Africa
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil’s bispecific dream is over | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
(TIL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
IPO Launch: How Zura Bio Limited stock valuations compare to rivalsNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Insider Buy: How Instil Bio Inc stock performs after earningsChart Signals & Short-Term Trading Alerts - moha.gov.vn
Rally Mode: Why Instil Bio Inc. stock is favored by top institutionsJuly 2025 Review & High Accuracy Trade Alerts - Улправда
What Wall Street predicts for Instil Bio Inc. stock price2025 Sector Review & Breakout Confirmation Alerts - Улправда
Aug Catalysts: Will Instil Bio Inc. stock outperform Dow Jones indexQuarterly Market Summary & Free Verified High Yield Trade Plans - DonanımHaber
Analyst Downgrade: Is Instil Bio Inc. stock a good choice for value investors2025 Price Action Summary & Weekly Sector Rotation Insights - Улправда
Is Instil Bio Inc. stock attractive for hedge fundsMarket Activity Report & AI Enhanced Trade Execution Alerts - DonanımHaber
Instil Bio Earnings Notes - Trefis
(TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Check out Instil Bio's stock price (5GT0-FF) in real time - CNBC
Is Instil Bio Inc a good long term investmentInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Responsive Playbooks and the TIL Inflection - news.stocktradersdaily.com
Instil Bio Inc (TIL) looking to reclaim success with recent performance - Setenews
Operating income of Instil Bio, Inc. – FWB:5GT0 - TradingView
Understanding the Setup: (TIL) and Scalable Risk - news.stocktradersdaily.com
Why Instil Bio Inc. stock is a value investor pickMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
4.73%
0.92%
자본화:
|
볼륨(24시간):